A family says a drug company led them to believe that their 16-year-old son could participate in a clinical trial for an experimental muscular dystrophy drug, but then went back on its word.

Federal regulators are working on a stronger label for a widely used diabetes drug, Byetta, after deaths continue to be reported despite earlier government warnings.

The biotechnology giant Genentech turned down a buyout offer from its majority owner Roche, saying the $43.7 billion takeover bid undervalues the company.

CVS Caremark said that it would buy its West Coast rival Longs Drugs Stores in a $2.54 billion deal that would allow it to expand in states like California.

Byetta, an injectable drug that lowers blood sugar, may help people with diabetes to live longer, according to the results of a major clinical trial.

ImClone Systems, the maker of the anticancer drug Erbitux, said a $4.5 billion takeover bid by Bristol-Myers Squibb “substantially undervalues” the company.

Byetta, an injectable drug that lowers blood sugar, may help people with diabetes to live longer, according to the results of a major clinical trial.

Schering-Plough said regulators had rejected Bridion, its drug to reverse the effects of anesthesia that had been heralded as a breakthrough product by analysts.

Schering-Plough said regulators had rejected Bridion, its drug to reverse the effects of anesthesia that had been heralded as a breakthrough product by analysts.

If they only had been more patient investors of ImClone Systems, Martha Stewart and others might have done just fine, and avoided jail time.